BBLG Q1 2021 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$180,924

Net Income

-$431,747

EPS (Diluted)

$-35.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$127,983

Free Cash Flow

-$127,983

Stock-Based Comp.

$15,000

Balance Sheet

Total Assets

$71,165

Total Liabilities

$14M

Stockholders' Equity

-$14M

Cash & Equivalents

$71,165

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$180,924	-$340,050	+46.8%
Net Income	-$431,747	-$596,900	+27.7%